These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31987812)

  • 1. Embelin averts MPTP-induced dysfunction in mitochondrial bioenergetics and biogenesis via activation of SIRT1.
    Rao SP; Sharma N; Kalivendi SV
    Biochim Biophys Acta Bioenerg; 2020 Mar; 1861(3):148157. PubMed ID: 31987812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganoderma lucidum extract ameliorates MPTP-induced parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis.
    Ren ZL; Wang CD; Wang T; Ding H; Zhou M; Yang N; Liu YY; Chan P
    Acta Pharmacol Sin; 2019 Apr; 40(4):441-450. PubMed ID: 29991712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperbaric Oxygen Therapy Improves Parkinson's Disease by Promoting Mitochondrial Biogenesis via the SIRT-1/PGC-1α Pathway.
    Hsu HT; Yang YL; Chang WH; Fang WY; Huang SH; Chou SH; Lo YC
    Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of mitochondrial phenotypes by endurance exercise contributes to neuroprotection against a MPTP-induced animal model of PD.
    Jang Y; Kwon I; Song W; Cosio-Lima LM; Taylor S; Lee Y
    Life Sci; 2018 Sep; 209():455-465. PubMed ID: 30144449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the root bark of Paeonia suffruticosa on mitochondria-mediated neuroprotection in an MPTP-induced model of Parkinson's disease.
    Kim HG; Park G; Piao Y; Kang MS; Pak YK; Hong SP; Oh MS
    Food Chem Toxicol; 2014 Mar; 65():293-300. PubMed ID: 24389454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treadmill Exercise Attenuates α-Synuclein Levels by Promoting Mitochondrial Function and Autophagy Possibly via SIRT1 in the Chronic MPTP/P-Induced Mouse Model of Parkinson's Disease.
    Koo JH; Cho JY
    Neurotox Res; 2017 Oct; 32(3):473-486. PubMed ID: 28656548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT1 Protects Dopaminergic Neurons in Parkinson's Disease Models via PGC-1α-Mediated Mitochondrial Biogenesis.
    Chen Y; Jiang Y; Yang Y; Huang X; Sun C
    Neurotox Res; 2021 Oct; 39(5):1393-1404. PubMed ID: 34251648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization.
    Lee Y; Park HR; Chun HJ; Lee J
    J Neurosci Res; 2015 May; 93(5):755-65. PubMed ID: 25677261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Singh A; Verma P; Balaji G; Samantaray S; Mohanakumar KP
    Neurochem Int; 2016 Oct; 99():221-232. PubMed ID: 27395789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
    Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
    J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Aminoethoxydiphenyl borate ameliorates mitochondrial dysfunctions in MPTP/MPP
    Vaidya B; Polepalli M; Sharma SS; Singh JN
    Mitochondrion; 2023 Mar; 69():95-103. PubMed ID: 36758857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
    Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
    Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
    Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
    Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unintended mitochondrial uncoupling effects of the FDA-approved anti-helminth drug nitazoxanide mitigates experimental parkinsonism in mice.
    Amireddy N; Puttapaka SN; Vinnakota RL; Ravuri HG; Thonda S; Kalivendi SV
    J Biol Chem; 2017 Sep; 292(38):15731-15743. PubMed ID: 28798236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside in the MPTP-induced mouse model of Parkinson's disease: Involvement of reactive oxygen species-mediated JNK, P38 and mitochondrial pathways.
    He H; Wang S; Tian J; Chen L; Zhang W; Zhao J; Tang H; Zhang X; Chen J
    Eur J Pharmacol; 2015 Nov; 767():175-82. PubMed ID: 26477638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
    Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
    J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid.
    Karunakaran S; Diwakar L; Saeed U; Agarwal V; Ramakrishnan S; Iyengar S; Ravindranath V
    FASEB J; 2007 Jul; 21(9):2226-36. PubMed ID: 17369508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Richardson JR; Caudle WM; Guillot TS; Watson JL; Nakamaru-Ogiso E; Seo BB; Sherer TB; Greenamyre JT; Yagi T; Matsuno-Yagi A; Miller GW
    Toxicol Sci; 2007 Jan; 95(1):196-204. PubMed ID: 17038483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Succinobucol, a Non-Statin Hypocholesterolemic Drug, Prevents Premotor Symptoms and Nigrostriatal Neurodegeneration in an Experimental Model of Parkinson's Disease.
    Santos DB; Colle D; Moreira EL; Hort MA; Godoi M; Le Douaron G; Braga AL; Assreuy J; Michel PP; Prediger RD; Raisman-Vozari R; Farina M
    Mol Neurobiol; 2017 Mar; 54(2):1513-1530. PubMed ID: 26852411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.